Researchers identify better hepatitis C treatment for people with HIV.
D000998:Antiviral Agents / Q000627:therapeutic use; D004337:Drug Carriers; D015658:HIV Infections / Q000150:complications*; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use
D000998:Antiviral Agents; D004337:Drug Carriers; D007370:Interferon Type I; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin